Gufic Biosciences Limited (GUFICBIO) Stock Statistics & Valuation Metrics

Gufic Biosciences Limited has a market cap or net worth of ₹38.44B. The enterprise value is ₹40.31B.

Gufic Biosciences Limited has 100,277,504 shares outstanding. The number of shares has decreased by -2.65% in one year.

Gufic Biosciences Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.69%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Gufic Biosciences Limited had revenue of 8.20B and earned 696.50M in profits. Earnings per share was 6.96.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Gufic Biosciences Limited pays an annual dividend of ₹0.1, resulting in a dividend yield of 0.03%

Gufic Biosciences Limited upcoming earnings date is ―, ―.

Gufic Biosciences Limited as a current ratio of 1.61, with Debt / Equity ratio of 55.93%

In the past 12 months, Gufic Biosciences Limited has paid 244.95M in taxes.

Gufic Biosciences Limited EV to EBITDA ratio is 2.22, with an EV/FCF ratio of 11.34.

Gufic Biosciences Limited has ₹193.96M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹193.96M billion.

Gross margin is 44.93%, with operating margin of 13.86%, and net profit margin of 8.50%.

The average price target for Gufic Biosciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―